P2B001 Study site Edison — Edison, New Jersey

P2B001 Study site Edison is a clinical research site located in Edison, New Jersey, United States 08820.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

P2B001 Study site Edison has participated in 1 clinical trials.

Therapeutic areas: Parkinson Disease, Early Parkinson's Disease.

Sponsors: Pharma Two B Ltd..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for P2B001 Study site Edison?

P2B001 Study site Edison has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has P2B001 Study site Edison conducted?

P2B001 Study site Edison has 1 clinical trials on record. Their work covers Parkinson Disease, Early Parkinson's Disease.

Is P2B001 Study site Edison accredited by Crixeo Health?

P2B001 Study site Edison has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about P2B001 Study site Edison?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.